It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...

But that's about to change, as weight-loss treatments will soon be available in pill form. RELATED: What Really Happens If ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of.

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the ...

These once-sizable artificial intelligence (AI) holdings for Google parent Alphabet have been paired down big-time over the ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 584.52% and ...

French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and ...

The Kardashians have been fighting claims that they use Ozempic for weight loss for years, so it was really only a matter of ...

Medicare may cover Wegovy for adults with cardiovascular disease and either obesity or overweight. Learn more about Medicare ...

GLP-1 is the active ingredient in many weight loss drugs, including Ozempic. It stands for glucagon-like peptide-1 and is a ...